VARENICLINE TARTRATE | N213978 | OYSTER POINT PHARMA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D.N.J. | 2026-01-12 | Active | — | |
| D.N.J. | 2025-11-21 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$79.64
per ml
Lowest NADAC/Unit
$79.64
per ml
Brand NDCs
1
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 73521003002TYRVAYA 0.03 MG NASAL SPRAY | $79.64 | ML | Brand | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9504644 | Oct 19, 2035 | — | — | — | — | |
| 9504645 | Oct 19, 2035 | — | — | Yes | — | — |
| 9532944 | Oct 19, 2035 | — | — | — | — | |
| 9597284 | Oct 19, 2035 | — | — | — | — | |
| 10456396 | Oct 19, 2035 | — | — | Yes | — | |
| 11224598 | Oct 19, 2035 | — | — | — | — | |
| 11903941 | Oct 19, 2035 | — | — | — | — | |
| 11903942 | Oct 19, 2035 | — | — | Yes | — | — |
| 11903943 | Oct 19, 2035 | — | — | — | — | |
| 11911380 | Oct 19, 2035 | — | — | — | — | |
| 12576080 | Oct 19, 2035 | — | — | — | — | |
| 12653824Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Oct 19, 2035 | — | — | Yes | — | — |